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Summary
Experimental evidence suggests that apicomplexan
parasites possess bipartite promoters with basal and
regulated cis-elements similar to other eukaryotes.
Using a dual luciferase model adapted for recombina-
tional cloning and use in Toxoplasma gondii,w e
showthatgenomicregionsﬂanking16parasitegenes,
which encompass examples of constitutive and
tachyzoite- and bradyzoite-speciﬁc genes, are able
to reproduce the appropriate developmental stage
expression in a transient luciferase assay. Mapping of
cis-acting elements in several bradyzoite promoters
led to the identiﬁcation of short sequence spans that
are involved in control of bradyzoite gene expression
in multiple strains and under different bradyzoite
induction conditions. Promoters that regulate the heat
shock protein BAG1 and a novel bradyzoite-speciﬁc
NTPase during bradyzoite development were ﬁne
mapped to a 6–8 bp resolution and these minimal
cis-elementswerecapableofconvertingaconstitutive
promoter to one that is induced by bradyzoite condi-
tions. Gel-shift experiments show that mapped cis-
elements are bound by parasite protein factors with
theappropriatefunctionalsequencespeciﬁcity.These
studies are the ﬁrst to identify the minimal sequence
elements that are required and sufficient for brady-
zoite gene expression and to show that bradyzoite
promotersaremaintainedina‘poised’chromatinstate
throughout the intermediate host life cycle in low
passage strains. Together, these data demonstrate
that conventional eukaryotic promoter mechanisms
work with epigenetic processes to regulate develop-
mental gene expression during tissue cyst formation.
Introduction
The apicomplexan protozoan Toxoplasma gondii is an
obligate intracellular parasite capable of invading any
nucleated mammalian cell, consequently causing disease
in a number of species, including humans. The distribution
of parasites across Europe and North America primarily
consists of three clonal lineages,Type I, II and III.Although
expressed sequence tag (EST) and genomic-based
polymorphism studies have shown the genetic diversity
between these lineages to be low (Ajzenberg et al., 2004;
Boyle et al., 2006a; Lehmann et al., 2006), there are
noticeable phenotypic differences. For example, the most
virulent strains of the parasite are of theType I background
(Sibley and Boothroyd, 1992). Additionally, differences in
migration, growth rate, the ability to differentiate to the cyst
forming bradyzoite stage and gene expression have been
observed (Radke et al., 2006; Taylor et al., 2006).
The advent of apicomplexan genome sequencing has
led to parallel analyses of the parasite transcriptome with
an emphasis on developmental gene expression. There
is a solid therapeutic rationale for this focus as clinical
sequelae in apicomplexan diseases are often attribu-
table to a speciﬁc life cycle stage. In toxoplasmosis, acute
pathology is associated with the growth of the tachyzoite
stage, while persistent infections are caused by the
encysted bradyzoite stage, which is not treatable with
current therapies. Global measurements of parasite gene
expression demonstrate that primary developmental tran-
sitions in the Apicomplexa are accompanied by temporal
changes in the level of mRNAs from genes that are dis-
persed across all parasite chromosomes (Cleary et al.,
2002; Singh et al., 2002; Radke et al., 2005). Stage-
speciﬁc mRNA expression accounts for a large fraction of
Plasmodiumtranscriptsandtherewaslittlesharedexpres-
sion between stages: nearly 200 genes were expressed
in the gametocyte, 41 were sporozoite-speciﬁc and 20% of
all transcripts were speciﬁc for the intraerythrocytic cycle
(reviewed in Llinas and DeRisi, 2004). Proteomic studies
appear to conﬁrm these results as over half of the 948
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uniquely expressed by a single developmental stage (Hall
et al., 2005). A global comparison of serial-analysis-of-
gene-expression (SAGE) tags (Velculescu et al., 1995)
from primary Type III strain libraries in Toxoplasma gondii
demonstrate that unique changes in mRNAlevels charac-
terize each developmental transition captured (Radke
et al., 2005). SAGE tags speciﬁc to each developmental
stage encompass 23% of the total tags sequenced and
ranged from 1.5% to 5.3% of the tags in each library.
Transcriptional exclusivity in developmental transitions
revealed by SAGE and microarray analysis supports the
notion that apicomplexan development follows a hierarchi-
cal order that is borne out by temporal changes in gene
expression proﬁles. Altogether, global analysis of gene
expression suggests that transcription initiation is a major
regulatory mechanism in apicomplexan parasites.
Studies in Plasmodium and Toxoplasma indicate that
the general eukaryotic transcriptional machinery whereby
RNA polymerase II transcribes protein encoding genes in
association with general transcription factors (GTFs) is
relatively conserved and active in these parasites (Li et al.,
1989; Fox et al., 1993; Coulson and Ouzounis, 2003;
Coulson et al., 2004; Callebaut et al., 2005; Meissner and
Soldati, 2005; Militello et al., 2005). Recently, a combina-
tion of two-dimensional hydrophobic cluster analysis and
proﬁle-based search methods using PSI-BLAST have
extended earlier investigations (Coulson et al., 2004;
Meissner and Soldati, 2005) such that ~60% of the known
eukaryotic GTFs are now recognized in the Plasmodium
genome, including important components of the TFIID
complex (Callebaut et al., 2005). Similar computational
surveys demonstrate the presence of GTFs in the Toxo-
plasma genome (Meissner and Soldati, 2005; White et al.,
2007).Setsofproteinsthatworkinconcertwiththegeneral
transcriptional machinery are the activating transcription
factors (ATFs). In higher eukaryotes, ATFs initiate gene
expression by binding to cis-acting (regulatory) promoter
element(s) and recruiting chromatin remodeling com-
plexes(Featherstone,2002;Liet al.,2004),whichcreatea
more favourable environment for the assembly of the RNA
polymerase complex (White et al., 2007). Numerous chro-
matin remodeling enzymes have been identiﬁed in Toxo-
plasma and a variety of histone modiﬁcations have been
observed at native parasite promoters (Saksouk et al.,
2005; Smith et al., 2005; Gissot et al., 2007). By compari-
son,littleisknownaboutapicomplexanATFsorthemecha-
nisms that activate gene-speciﬁc transcription. This is one
of the major gaps in our knowledge of apicomplexan
biologyandﬁllingthisdeﬁciencyhasimportantimplications
for understanding parasite development.
In this study, we use low passage Toxoplasma isolates
to establish in cell culture models that promoters control-
ling bradyzoite genes have active chromatin conﬁgura-
tions in advance of induced changes in mRNA levels. We
show that cis-acting elements regulating the expression of
bradyzoite promoters have deﬁnable nucleotide composi-
tions, and these elements retain their activity when intro-
duced into unrelated promoters. We further show that
functionally mapped cis-elements are bound by protein
factors with the appropriate sequence speciﬁcity.
Results
Global mRNA proﬁling of Type I, II and III strains
Previous studies suggested that speciﬁc bradyzoite
genes were differentially expressed in the three major
lineages common to North America and Europe (Radke
et al., 2006). In order to determine if these differences
extended to the global transcriptome, we characterized
whole-cell mRNA levels in both tachyzoite and bradyzoite
populations from three primary strain isolates differenti-
ated in vitro. It is well understood in the ﬁeld that long
passage history is associated with the loss of develop-
mental competence (Frenkel et al., 1976). Therefore, the
Type I-GT1, Type II-Me49B7 and Type III-CTG strains
studied here were maintained at < 20 cell culture pas-
sages from the oocyst stage and are capable of complet-
ing both intermediate and deﬁnitive host life cycles. These
experiments used newly constructed Affymetrix Gene-
Chips that include probe sets for ~8000 genes, and we
assessed the induction of bradyzoite genes using a strong
inducer of bradyzoite differentiation, Compound 1 (Radke
et al., 2006). All known bradyzoite genes (Fig. 1; e.g.,
BAG1:ToxoDB gene #55.m00009, LDH2:80.m00010,
ENO1:59.m03411 and B-NTPase:42.m03416 are indi-
cated) were strongly induced in both Type II-Me49B7 and
III-CTG strains, while the Type I-GT1 strain retained a
greater tachyzoite character under Compound 1 induction
based on mRNA expression (and also shows lower cyst
wall formation, Radke et al., 2006) with the exception of
SAG4.2 (72.m00003) mRNA, which showed induction in
Type I-GT1 under these conditions. All genes have been
listed in the clustered heat map presented in Fig. S1. It
was interesting that basal expression of bradyzoite genes
was generally higher in tachyzoites of the Type II-Me49B7
strain, while tachyzoites of the Type I-GT1 and III-CTG
strains had much lower mRNA levels for the same
bradyzoite genes (Fig. 1B). These data conﬁrm the induc-
tion of a novel bradyzoite-speciﬁc NTPase (B-NTPase)
previously discovered by SAGE in a Type III strain (Radke
et al., 2005) and further validates that bradyzoite gene
expression in Type II strains has a higher spontaneous
expression (Radke et al., 2005; Boyle et al., 2006b).
Although similar results were obtained for the above men-
tioned bradyzoite genes when exposing Type II-Me49B7
and III-CTG strains to alkaline media for a similar time
frame, Compound 1 and alkaline media have gene
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suggesting that there is a core set of genes common to
bradyzoite differentiation regardless of condition as well
as sets of genes which are uniquely regulated by each
condition (data not shown).
Histone acetylation status of bradyzoite promoters in
low-passage strains
Recent results correlating histone modiﬁcations such as
acetylation and methylation with promoter activity has
raised the possibility of epigenetic control in developmen-
tal gene expression in Toxoplasma (Saksouk et al., 2005;
Sullivan and Hakimi, 2006; Gissot et al., 2007). Given the
difference in bradyzoite gene expression between the
three genotypic lineages (Fig. 1), we explored whether
differences in mRNA expression might be explained by
strain-speciﬁc changes in chromatin. Three bradyzoite
promoters (BAG1, LDH2 and B-NTPase) were examined
for histone acetylation patterns in low-passage strains.
Regulation of these genes during natural and in vitro
bradyzoite differentiation is well documented in the pub-
lished literature (Bohne et al., 1995; Yang and Parmley,
1995) and is evident in SAGE (Radke et al., 2005) and
EST data sets (Kissinger et al., 2003) and in the microar-
ray analysis shown in Fig. 1.
Fig. 1. Regulation of mRNA expression
during bradyzoite differentiation in
low-passage Type III-CTG, Type I-GT1 and
Type II-Me49B7 strains.
A. The expression of 267 genes that were up-
or downregulated by Compound 1 treatment
in the Type-II and III strains (3 mM drug for
48 h) are shown (for a list of these genes see
Fig. S1). Each line represents one gene in the
gene list allowing one to trace the expression
of the genes across the experiment. Colouring
of the lines (fold scale to the right) is ﬁxed
across the graph by the expression level of
just one sample, Type III Compound 1
(CMPD1) (yellow-to-red = upregulated;
yellow-to-blue = downregulated). Genes
induced by Compound 1 include all known
bradyzoite genes. BAG1, LDH2, ENO1,
SAG4.2 and B-NTPase mRNAs are among
the highest expressed mRNAs detected the
Type III-CTG and Type II-Me49B7 strains
induced by Compound 1 (indicated by labels
and with line graphs highlighted in black).
Note that the group of bradyzoite genes that
are coloured in red or highlighted in black
based on the mRNA expression in the Type
III-CTG strain are minimally increased in Type
I-GT1 parasites exposed to Compound 1.
Each data point shown represents
RMA-normalized values from two independent
biological replicates.
B. RMA-normalized ﬂuorescent values for ﬁve
known bradyzoite genes are listed for three
strains maintained as tachyzoites or induced
by Compound 1.
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assays on extracts from all three strains using antibodies
speciﬁc for acetylated histone H3 or H4 based on
previously published protocols (Saksouk et al., 2005).
Bradyzoite conversion efficiencies for the three strains
was assessed independently by FITC-Dolichos biﬂorus
lectin ﬂuorescence (Coppin et al., 2003). Under the con-
ditions of induction used here, Type II-Me49B7 and Type
III-CTG strains convert at > 70%, while Type I-GT1 strain
infected cultures had < 30% tissue cysts (data not shown)
(Radke et al., 2006).
In low-passage Type I-GT1 and III-CTG strains main-
tainedastachyzoites(priortoinduction),histoneH3acety-
lation of bradyzoite promoters (BAG1, LDH2, B-NTPase)
was extensive and comparable to H3 acetylation of pro-
moter regions ﬂanking the tachyzoite-speciﬁc gene,
SAG2A (59.m00008), and the constitutive gene, b-tubulin
(57.m00003) (Fig. 2A–C), although mRNAlevels for these
bradyzoite genes are nearly undetectable in tachyzoites of
thesestrains(Fig. 1B).ThelevelofH3acetylationonthese
promoters was unchanged or slightly lower following Com-
pound 1 induction in these strains with the LDH2 promoter
becoming hypoacetylated in the Type I-GT1 strain. Acety-
lation of histone H3 was detected on the BAG1 and
B-NTPase promoters inType II-Me49B7 strain tachyzoites
(Fig. 2A and C), although these levels were lower and
acetylated H3 was not detected associated with the LDH2
promoter in Type II-Me49B7 tachyzoites (Fig. 2B). Upon
Compound1induction,H3acetylationwasobservedonall
three promoters in the Type II-Me49B7 strain and acety-
lated H4 also increased in association with the BAG1
promoter in this strain (Fig. 2A). Interestingly, LDH2 and
BAG1 promoters in the Type I-RH strain (Fig. 2A and B)
were associated with signiﬁcantly less H3 acetylation than
anyofthelow-passagestrains.H3acetylationoftheBAG1
and LDH2 promoters in Type I-RH was signiﬁcantly
reduced (Fig. 2A) or undetectable, respectively, in the
tachyzoites as well as induced bradyzoites (Fig. 2B).
In general, these results are consistent with the pre-
activation, or ‘poised’ nature, of bradyzoite promoters in
low-passage isolates, while long-term passage in cell
culture may lead to histone hypoacetylation on these
same promoters. However, the chromatin differences
between tachyzoites of the three strains (particularly
the lower active chromatin associated with the Type
II-Me49B7 strain) was surprising given the clearly higher
basal expression of BAG1, B-NTPase and LDH2 mRNAs
detected in Type II-Me49B7 tachyzoites (Fig. 1B).
Adaptation of the dual luciferase reporter assays to the
Toxoplasma model
The lack of tight correlation between chromatin state and
mRNAexpression during bradyzoite differentiation inType
II and III strains indicates that other promoter mechanisms
are likely key to the changes in developmental gene
expression. Transcription studies in Toxoplasma are rela-
tively limited with only a few promoters examined. Given
this deﬁciency, we adapted the dual luciferase model
(ﬁreﬂy/Photinus pyralis and renilla/Renilla reniformis
luciferase) (Promega, 2006) for use in Toxoplasma in
order to undertake a detailed mapping study of several
bradyzoite promoters. The basic construct for these
studies features a variable length promoter fragment that
includes the 5′-untranslated region (UTR) as cis-elements
may lie on either side of the transcription start (Chow and
Wirth, 2003). The promoter-5′-UTR fragment is produced
by PCR with small recombination sites (attB) incorporated
at each end for modular cloning. The fragment is cloned 5′
of the ﬁreﬂy luciferase ORF by recombination (the 3′-attB2
site is translated; Hartley et al., 2000). The 3′-UTR and
poly(A) sites are contributed by the Toxoplasma dihydro-
folate reductase-thymidylate synthase (DHFR-TS) gene
(Matrajtet al.,2004)containedinthevectorasourstudies,
and those of others (Bohne and Roos, 1997; Bohne et al.,
1997; Kibe et al., 2005) demonstrate the 3′-UTR is not
required for developmental gene expression. The recom-
bination cloning model (Hartley et al., 2000) used here
improves ﬂexibility and allows rapid cloning of multiple
promoter regions and straightforward deletion and substi-
tution mutagenesis (Carey and Smale, 2000) to identify
regions containing bradyzoite gene cis-elements.
To conﬁrm the role of intergenic regions in regulating
developmental gene expression in Toxoplasma,1 6
5′-intergenic ﬂanking regions from previously known
bradyzoite- and tachyzoite-speciﬁc genes were tested as
well as the promoter region ﬂanking B-NTPase (Radke
et al., 2005). Promoter regions comprising 1–1.5 kbp of
5′-ﬂanking region including the 5′-UTR were fused to the
ﬁreﬂy luciferase via recombination cloning and constructs
were evaluated in a transient transfection format using the
a-tubulin-renilla luciferase (tubulin promoter comprised
2700 bp 5′-ﬂanking region) cotransfection control to nor-
malize differences in electroporation efficiency. Native
a-tubulin mRNA levels are relatively unchanged during
differentiation (Dzierszinski et al., 2001) and varied less
than twofold in parasites transiently transfected and
induced to enter the bradyzoite pathway with Compound
1 or pH 8.2 media (data not shown). Luciferase expres-
sion is induced under Compound 1 conditions for six
bradyzoite promoter constructs; LDH2, SAG4.2, SAG4A
(72.m00004), BAG1, B-NTPase and cyst wall 65 kDa
protein (59.m00006) (Fig. 3A; all primers used for pro-
moter constructs in these and all experiments below are
listed in Table S2). Note that the BSR4 (641.m01561)
promoter construct was constitutively expressed in these
assays, which is consistent with the SAGE frequencies
obtained for this gene and the revised assignment of this
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promoters are poised for activation in
low-passage strains.
A. ChIP results for the BAG1 (B), SAG2A (S)
and b-tubulin (T) promoter regions in three
major genetic lineages. The BAG1 promoter
was associated with acetylated histones
(H3 or H4) in low-passage tachyzoites (left
panels) of all major strains (Type I-GT1, Type
II-Me49B7 and Type III-CTG) and the levels
detected were similar to acetylated H3 levels
in the tachyzoite-speciﬁc gene SAG2A or the
b-tubulin gene, which is constitutively
expressed in both tachyzoite and bradyzoites.
The levels of H3 or H4 acetylation in these
strains was largely sustained in parasites
stimulated to differentiate with 3 mM
Compound 1 (CMPD1) for 48 h (right panels).
Acetylated H3 associated with the BAG1
promoter in the lab-adapted, Type I-RH strain
was minimal in tachyzoites or parasites
exposed to Compound 1. AcH3, AcH4 = ChIP
with antibody speciﬁc for acetylated histone
H3 or H4; No Ab = no antibody control ChIP;
Input = input DNA collected prior to
immunoprecipitation.
B. ChIP of the LDH2 promoter region in
different strains. LDH2 promoter has complex
H3 acetylation patterns in different strains. In
tachyzoites, we observed strong H3
acetylation associated with the LDH2
promoter in Type I and III strains, while Type
II strain tachyzoites the promoter was
hypoacetylated (left panels). Following
induction by Compound 1, hyperacetylated H3
was detected in the LDH2 promoter from
Type II-Me49B7 and III-CTG parasites, while
this promoter became hypoacetylated in the
Type I-GT1 strain (right panels). In the cell
culture adapted Type I-RH strain, the LDH2
promoter was hypoacetylated regardless of
stage or culture condition.
C. ChIP of the B-NTPase promoter regions
in different strains. B-NTPase promoter is
associated with substantial H3 acetylation in
both tachyzoite and Compound 1-induced
extracts in all three low-passage strains with
the level of H3 acetylated in Type II-Me49B7
tachyzoites and bradyzoites lower than the
Type I-GT1 and Type III-CTG strains.
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throyd, 1998; Van et al., 2007).Anumber of other promot-
ers tested had moderate to high levels of expression in
tachyzoites (Fig. S2) including SAG1 (p30, 44.m00009),
fructose 1,6 bisphosphate aldolase (50.m00005), GRA6
(63.m00002), ROP4 (83.m02145), GAPDH (83.m00003),
MIC3 (641.m00002) and IMC1 (44.m00004) as well as
DHFR and a-tubulin, which have served as controls for
the studies below. Thus, each promoter region tested
conveyed expression in the appropriate developmental
stage where mRNA levels are highest as reﬂected in the
frequency of SAGE tags (Radke et al., 2005) or microar-
ray data in Fig. 1A. These results indicate that Toxo-
plasma 5′-intergenic regions contain regulatory elements
that control developmental gene transcription.
To verify that the transient expression of the promoter–
luciferase constructs were authentically regulated when
integrated into the Toxoplasma genome, we have devel-
oped several transgenic lines from the Type II-Prugniaud
strain (cyst forming) that possesses an integrated copy of
the ﬁreﬂy luciferase coding region under control of the
BAG1 promoter (results for clone IC2 is shown in Fig. 3B).
Induced luciferase protein expression in these strains fol-
lowed a kinetics (Fig. 3B) that paralleled native BAG1
mRNA and protein expression (Radke et al., 2006), and
luciferase could be colocalized in parasites induced to
express native BAG1 by two colour immunoﬂuorescence
Fig. 3. Intergenic genomic regions control developmental gene
expression.
A. Promoter regions from bradyzoite genes are strongly induced by
3 mM Compound 1 treatment. Several bradyzoite promoters
engineered to drive the expression of ﬁreﬂy luciferase were tested
under tachyzoite (open bars) and bradyzoite induction (solid bars)
conditions. Type III-VEGmsj tachyzoites were electroporated with the
appropriate plasmid combination (see Experimental procedures),
inoculated into HFF monolayers (T25cm
2 ﬂasks), allowed to grow
overnight, and then experimental ﬂasks were placed under 3 mM
Compound 1 for 48 h. Four readings were collected for ﬁreﬂy and
renilla luciferase activity for each promoter construct. Fold increase
in luciferase activity in comparison to a-tubulin-renilla controls are
plotted for each promoter construct tested under tachyzoite or
bradyzoite-induction conditions. All promoters exhibited strong
induction following Compound 1 induction with the exception of
BSR4, which has been shown to be equally expressed in
tachyzoites and bradyzoites (Van et al., 2007).
B. Integrated promoter constructs in transgenic parasites display
natural developmental expression. Clone Type II-Prugniaud-IC2
expresses an integrated copy of the ﬁreﬂy luciferase controlled by
the BAG1 promoter (-1197 bp region). Type II-Prugniaud-IC2
parasites were inoculated into HFF monolayers, allowed to grow
overnight and then placed under 3 mM Compound 1. Infected
monolayers were assessed for luciferase activity (average of four
readings) at the indicated time points. Luciferase induction is ﬁrst
observed between 24 and 36 h and increases dramatically in
parallel to native BAG1 protein (Radke et al., 2006).
C. Differentiation conditions vary signiﬁcantly in their strength of
induction. Type II-Prugniaud-IC2 parasites (2 million) were
inoculated into HFF monolayers, allowed to grow overnight and
then placed under six different induction conditions (see
Experimental procedures). Drug concentrations: Compound
1 = 3 mM or pyrolidine dithiocarbamate = 100 mM. Infected
monolayers were assayed for luciferase activity
(4-readings/condition) using standard protocols (Promega manual
#TM058) at 72 h post-treatment. Results were calculated as ratios
of induced/untreated control (e.g. Compound 1 = 20 970 normalized
light units, pH 8.2 = 4838 units, and PDTC = 2900 units) and then
graphed in comparison to the pH 8.2 values set to 100%. The order
of strength of induction: Compound 1 > pH 8.2 > PDTC > CO2 and
arginine depletion > high temperature.
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afforded by the luciferase reporter, we evaluated the rela-
tive strengths of known methods to induce bradyzoite
differentiation (Fig. 3C). Luciferase activity ranged ~3000-
fold in these experiments and parasite growth-inhibition
consistently correlated with increased luciferase activity
(Bohneet al.,1997).Therelativestrengthofinductionwas:
3 mM Compound 1 (Donald et al., 2002; Radke et al.,
2006), > pH 8.2 media (Weiss et al., 1995), > 100 mM pyr-
rolidine dithiocarbamate (Djurkovic-Djakovic et al., 2005),
> CO2 depletion (Bohne and Roos, 1997), > low-arginine
(Fox et al., 2004), > high temperature and (Soete et al.,
1994). These results demonstrated that Compound 1 was
comparable to or greater than alkaline media in stimulating
luciferase expression in Type II-Prugniaud-IC2 (see also
Radke et al., 2006). By comparison, we did not observe
strong induction of luciferase activity using published
methods of arginine (Fox et al., 2004) or CO2 depletion
(Bohne and Roos, 1997), or high temperature as these
methodswerenotaseffectiveundertherelativelyhighmoi
(1:1) and short time frame we used in these experiments
(48 h). We also observed a lack of growth inhibition using
Arg and CO2 conditions, and high temperature conditions
that are congruent with the low levels of luciferase reporter
expression detected in these cultures.
Sequential and internal deletion mapping of
bradyzoite promoters
Experimental identiﬁcation of transcription factors respon-
sible for bradyzoite gene expression follows a logical
sequence that begins with careful mapping of the nucle-
otide elements in promoters using in vitro functional
assays. To determine whether cis-element sequences
responsible for the induction of bradyzoite genes in Type
II and III strains could be mapped to a high resolution in
Toxoplasma, we undertook a study to map ﬁve different
bradyzoite promoters in a Type III strain using the dual-
luciferase assay. Sequential deletion of promoters con-
trolling BAG1, LDH2, B-NTPase, SAG4.2 and cyst wall
65 kDa protein (Fig. 4 and Fig. S3) demonstrates that
regulatory cis-elements have deﬁnable locations that are
positioned relatively close to the start of transcription in
each promoter. Major transcriptional start sites occur at
-284 with respect to BAG1 (Bohne et al., 1995) and at
-330 bp for LDH2 and -370 bp for B-NTPase (mapped by
5′-RACE, data not shown).
Sequential deletion of the BAG1 promoter identiﬁed a
region between -385 and 365 bp with respect to the
BAG1 translational start (Fig. 4A). Further internal dele-
tion mapping conﬁrmed this region as being important
to BAG1 promoter induction (Fig. 4B), while deletions on
either side of this element had little or no effect on the
induction of luciferase expression. It should be noted that
the cis-elements identiﬁed here falls close to a region
previously linked to bradyzoite induction in the BAG1
promoter (Bohne et al., 1997). Utilizing a similar deletion
strategy, we identiﬁed the region -611–403 bp as impor-
tant for induction of the B-NTPase promoter (Fig. 4C). A
ﬁnal series of overlapping 10 bp deletion constructs
further resolved the inducible element in the B-NTPase
promoter to nucleotides -452–443 bp from the transla-
tional start (Fig. 4D).
SequentialdeletionsintheLDH2promoterassociatethe
region -508–291 bp with bradyzoite induction (Fig. S3A)
and additional internal deletion mapping revealed two dis-
tinct elements, between -482–427 bp and -391–381 bp
(Fig. S3B). Finally, sequential deletions in the SAG4.2
promoter link bradyzoite induction to the region -616–
416 bp (Fig. S3C) and a region -899–688 bp in the cyst
wall protein promoter (Fig. S3D). Taken together, deletion
constructs conﬁrm and reﬁne the location of cis-elements
mediating bradyzoite gene expression to the promoter
regions -385–365 in BAG1, -452–443 in B-NTPase,
-482–427 and -391–381 in LDH2, -616–416 in SAG4.2
and -899–688 in the 65 kDa cyst wall protein promoter.
Site-directed mutagenesis of the BAG1 and
B-NTPase promoter
In order to determine the minimal sequence required to
induce expression, the BAG1 and B-NTPase promoters
were further ﬁne mapped by site-directed mutagenesis.
Mutagenesis was carried out in full-length promoter frag-
ments (1495 bp for B-NTPase and 1195 bp for BAG1)
using inverse or overlap extension PCR (Ho et al., 1989)
with the ﬁnal PCR fragment recombinationally cloned into
the ﬁreﬂy luciferase vector. Two mutagenesis strategies
were used with targeted transition of three contiguous
bases(A–GorT–C)usedforthe-385–365 bpregionofthe
BAG1 promoter or a 4 bp AAAA substitution used in the
-467–438 bp region of the B-NTPase promoter (Table 1).
Transient transfection of site-directed BAG1 promoter
mutants in Type III-VEGmsj strain identiﬁed a single 6 bp
segment (TACTGG) that was critical for Compound 1
induction (BAG1 promoter mutant #2 and #3, Table 1). By
contrast,alterationofTGTG(B-NTPasemutant#3),CAGC
(mutant #6) and GCAC (mutant #7) to AAAA within the
-458–439 cis-element region of the full-length promoter
fragment revealed that each was required for induced
expression of the B-NTPase promoter. These results
indicate that the B-NTPase promoter has two distinct
sequence elements, involving a TGTGTG repeat and the
4 bp sequence CAGC. Interestingly, in both of these pro-
moters ﬁne mapping did not identify a true palindromic
sequence as being required for the induction of bradyzoite
gene expression. Sequence elements similar to those
identiﬁed in the BAG1 and B-NTPase promoters can be
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induction of the LDH2, SAG4.2 and 65 kDa cyst wall
promoters (Fig. S4), although mutations in these
sequence elements have not yet been functionally tested
using the dual luciferase assay.
Different bradyzoite induction conditions act through
common promoter cis-elements
Characterization of the bradyzoite cis-elements in the pre-
vious mapping studies used a single induction method and
a Type III strain. To determine whether the promoter
sequences identiﬁed are the key induction elements in
these promoters, we compared the two most effective
methods for inducing bradyzoite gene expression (Com-
pound 1 versus pH 8.2 media Fig. 3C) in the Type I-RH,
II-Me49B7 and III-VEGmsj strains. Luciferase activity from
the full-length construct for BAG1, B-NTPase and LDH2
promoters was induced to a similar level in Type II and III
strains under Compound 1 or alkaline media (Fig. 5 and
Table S1). The induction levels of the full-length promoter
constructintheTypeI-RHstrainwereonaveragethreefold
lower (Table S1) consistent with the reduced efficiency we
have observed in bradyzoite switching for Type I strains
Fig. 4. Sequential and internal deletion of the BAG1 and B-NTPase promoters. Transient transfections were performed in duplicate and
ﬁreﬂy and renilla luciferase activity was assayed sequentially in each of the samples. Fireﬂy luciferase results were normalized by
a-tubulin-renilla levels and graphed as the induced level of expression as compared with the full-length promoter construct (relative response
ratio). For each sequential deletion construct, fold change was also determined with respect to the level of luciferase expression in the
a-tubulin-renilla control (fold change values and standard deviations in parentheses are listed adjacent each deletion construct). Nucleotide
positions in these deletion studies are referenced with respect to the start of translation (+1) in each construct.
A. Results of sequential deletion of the BAG1 promoter compared with the full-length 1195 bp promoter construct.
B. Results of internal deletion of the BAG1 promoter. Note the regions identiﬁed by sequence deletion are referenced by arrow in this internal
deletion series.
C. Results of sequential deletion of the B-NTPase promoter (fold change values also included) with respect to the 1495 bp full-length
promoter.
D. A series of overlapping 10 bp internal deletions further reﬁne the required sequence elements ﬁrst identiﬁed by the sequential deletion
between -611–403 bp in this promoter (see arrow).
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RRR (%)
A. Mutagenesis of the Brady-NTPase -1495 bp promoter
WT – TGAC GGTG CGTG TGTG CGTG CAGC GCAC TC 100
Mut1 – TGAC AAAA CGTG TGTG CGTG CAGC GCAC TC 47
Mut2 – TGAC GGTG AAAA TGTG CGTG CAGC GCAC TC 47
Mut3 – TGAC GGTG CGTG AAAA CGTG CAGC GCAC TC 3
Mut4 – TGAC GGTG CGTG TGTG AAAA CAGC GCAC TC 51
Mut5 – TGAC GGTG CGTG TGTG CGTG AAAA GCAC TC 11
Mut6 – TGAC GGTG CGTG TGTG CGTG CAGC AAAA TC 15
B. Mutagenesis of the -1195 bp BAG1 promoter
WT – CGG TAC TGG CCG CAC GGT TT 100
Mut1 – TAA TAC TGG CCG CAC GGT TT 118
Mut2 – CGG CGT TGG CCG CAC GGT TT 5
Mut3 – CGG TAC CAA CCG CAC GGT TT 8
Mut4 – CGG TAC TGG TTA CAC GGT TT 47
Mut5 – CGG TAC TGG CCG TGT GGT TT 236
Mut6 – CGG TAC TGG CCG CAC AAC TT 120
Mut7 – CGG TAC TGG CCG CAC GGT CC 90
RRR = relative response ratio as compared with full-length promoter. Bold nucleotides indicate substitutions.
Fig. 5. BAG1, B-NTPase and LDH2 promoter induction in Type I, II and III parasites under two different induction conditions.
A. Type III-VEGmsj, Type II-Me49B7 and Type I-RH strains were transiently transfected in duplicate and induced by 3 mM Compound 1
(CMPD1) or pH 8.2 media conditions (48 h). Infected monolayers were harvested at the appropriate times (parasite + HFF cells), lysates
prepared and luciferase activity was determined (4-readings/condition). Fireﬂy luciferase results are normalized by a-tubulin-renilla levels and
reported as the relative induced expression levels in reference to the corresponding full-length promoter (relative response ratio; fold change
values for these experiments are listed in Table S1). Three promoters were tested, BAG1, B-NTPase and LDH2, with two internal deletion
constructs compared with three promoter constructs that show maximum inductive activity (BAG1 -1195, B-NTPase -801 and LDH2 -708).
Internal deletion in the BAG1 -457–365 bp, B-NTPase -477–441 bp and LDH2 -426–377 bp promoters of the critical cis-elements ablate
induction of these promoters in all three strains regardless of the induction condition, while neighbouring deletions in each promoter retained
at least 50% of the activity of the fully active promoter construct. Each control internal deletion behaved similarly in each strain including the
strong induction observed when a putative repressor element that lies between -340 and 277 bp of the LDH2 promoter was deleted.
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difference between strains or induction conditions in tran-
sient transfections of key internal deletion constructs
(Fig. 5).Transfection of constructs where the key inducible
cis-element in each promoter had been deleted (BAG1,
-457–365 bp; B-NTPase, -477–441 bp; LDH2, -426–
377 bp) showed a complete loss of induced expression in
all three strains. Control deletions outside these critical
cis-element regions behaved similarly in Type II-Me49B7
and III-VEGmsj strains under the two induction methods.
These patterns extended to the apparent repressor
elementintheLDH2promoter(-340–277 bp),whichwhen
deleted led to a dramatic upregulation of luciferase activity
(Fig. 5). These results indicate that the transcriptional
mechanisms activated by both induction conditions
operate via the same cis-regulatory elements in each
promoterinallthreestrains.DiminishedexpressioninType
I-RH is not likely to be due to promoter mutation as Type
I-RH promoter constructs were actively expressed when
transfected into a Type III strain and there are no polymor-
phisms in the critical cis-element regions for the BAG1,
B-NTPase and LDH2 promoters in the three strains (data
not shown). Therefore, the explanation for differences in
developmental gene expression between the strains is
likely to be the response to inductive conditions rather than
in the core promoter sequence elements.
BAG1 and B-NTPase promoter cis-elements are
sufficient for induced expression
We next explored whether the key BAG1 (-386–355) or
B-NTPase (-462–438) cis-elements were autonomous
acting sequences. DHFR-TS is encoded by a constitutive,
but low-level transcript that is unaffected by conditions
that induce bradyzoite gene expression. In recently con-
ducted microarray studies, DHFR mRNA levels were
found to be constitutive in all three clonal strains (Types
I-III) during tachyzoite to bradyzoite development and
also in growth-synchronized tachyzoite populations (M.S.
Behnke and M.W. White, unpublished). We cloned the
1000 bp genomic fragment ﬂanking the DHFR-TS coding
region (Matrajt et al., 2004) into the luciferase cassette
by recombination and then introduced by inverse PCR
unique Avr-II/Bgl-II sites 100 bp upstream of the major
transcription start site at -369 bp (Matrajt et al., 2004).
The DHFR-TS promoter with or without the Avr-II/Bgl-II
sites was tested for expression in Type III strain tachyzoi-
tes and Compound 1-induced parasites and no difference
in expression or induction was detected (data not shown).
One to three copies of either the BAG1 or B-NTPase
cis-element were then introduced into the unique Avr-II/
Bgl-II sites in the modiﬁed DHFR-TS promoter using
oligonucleotide linkers. The introduction of either cis-
element sequence successfully converted the DHFR-TS
promoter into one that is induced by Compound 1 (Fig. 6).
Following induction with Compound 1 there was a step-
wise increase in luciferase activity compared with the
wild-type DHFR-TS promoter construct based on the
number of cis-element copies (Fig. 6). These data indi-
cate the BAG1 and B-NTPase cis-elements identiﬁed by
functional mapping are sufficient to confer increased
expression during bradyzoite differentiation.
Detection of DNA binding activity is speciﬁc for
B-NTPase or BAG1 functional cis-element sequences
(EMSA assays)
Eukaryotic gene induction involves transcription factors
that recognize speciﬁc cis-regulatory elements contained
within promoters. Using DNA fragments carrying the
minimal cis-elements functionally mapped in B-NTPase
and BAG1 (-467–433 and -385–365 respectively), we
performed electromobility shift assays (EMSA) to deter-
Fig. 6. BAG1 and Brady-NTPase cis-elements are autonomous in
Toxoplasma. Copies (1–3¥) of the BAG1 or B-NTPase cis-element
(see Table 1) were introduced into the DHFR promoter (see
diagram). The cis-elements were placed 100 bp upstream of the
major start of transcription at -369 bp (Matrajt et al., 2004). The
Type III-VEGmsj strain was transiently transfected in duplicate and
induced by 3 mM Compound 1. Infected monolayers were
harvested at the appropriate times (parasite + HFF cells), lysates
prepared, and luciferase activity was determined
(4-readings/condition). Fireﬂy luciferase results are normalized by
a-tubulin-renilla levels and reported as the relative induced
expression levels in reference to the corresponding full-length
promoter (relative response ratio). No change in luciferase
expression was observed under tachyzoite conditions with any
construct (data not shown). However, 48 h following 3 mM
Compound 1 addition there was a stepwise increase in luciferase
activity compared with the WT-DHFR promoter construct based on
the number of cis-element copies.
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these elements. Nuclear extracts prepared from Type III-
CTG strain induced to differentiate with Compound 1 were
incubated with [32P]-labelled DNA fragments and in some
cases unlabelled competitor DNA was added to show
additional speciﬁcity. EMSA assays using a radiolabelled
DNA fragment encoding the B-NTPase cis-element
showedonedominantgelshiftcomplex(Fig. 7,complex2)
with a second minor complex that had a slower mobility
(complex 1). Competition with unlabelled wild-type B-
NTPase cis-element effectively competed the radiola-
belled DNA probe (Fig. 7 see 5¥ and 25¥ fold competitor,
lanes 3, 4), while the addition of unlabelled B-NTPase
mutant DNA did not diminish complex formation at two
levels of excess competitor (Fig. 7 lanes 5, 6). Consistent
with the unique sequences associated with these two
cis-elements (BAG1 versus B-NTPase, Table 1), 25-fold
excess unlabelled BAG1 cis-element also did not effec-
tively compete for binding with the labelled B-NTPase
probe.
The pattern of protein–DNA complexes was more
complex when labelled DNAfragment encoding the BAG1
cis-element was incubated with Type III-CTG nuclear
extracts. Three distinct complexes were observed with
this labelled DNA that differed in signal intensity (Fig. 8).
To sort out the speciﬁcity of these complexes, we evalu-
ated 5¥ and 25¥ unlabelled DNA that encoded the wild-
type or mutant cis-element BAG1 sequence to compete
for binding. The result of this experiment showed that a
single protein complex appeared to have the appropriate
speciﬁcity based on functional mapping of the BAG1 pro-
moter (Fig. 8). Unlabelled WT-BAG1 DNA efficiently com-
Fig. 7. B-NTPase EMSA assay. The B-NTPase cis-element forms
sequence speciﬁc protein–DNA complexes. Incubation of
[
32P]-end-labelled DNA encoding B-NTPase cis-element
(-467–438 bp, see Table S2 for all primer designs) with nuclear
extracts from Type III-CTG parasites induced for 48 h with 3 mM
Compound 1 (CMPD1). Note the major complex (complex 2)
formed with labelled Brady-NTPase cis-element fragment was not
diminished by unlabelled B-NTPase mutant #3 sequence (Table 1)
or with unlabelled BAG1 cis-element. Lane 1, probe alone; lane 2,
nuclear extract + probe; lanes 3–7, probe + extract + cold
competitor. Lanes 3 and 4, unlabelled wild-type B-NTPase
competitor at 5- and 25-fold excess respectively. Lanes 5 and 6,
unlabelled B-NTPase mutant #3 (Table 1 and Table S2) at 5- and
25-fold excess. Lane 7, 25-fold excess unlabelled BAG1
cis-element.
Fig. 8. BAG1 EMSA assay. Identiﬁcation of sequence speciﬁc
protein–DNA interactions using the BAG1 cis-element. Incubation of
[
32P]-labelled BAG1 cis-element (-386–355 bp, Table S2 primer
designs) with nuclear extracts from Type III-CTG parasites induced
for 48 h with Compound 1 (CMPD1). Lane 1, probe alone; lane 2,
nuclear extract + probe; lanes 3–7, probe + extract + cold
competitor. Lanes 3 and 4, unlabelled wild-type BAG1 competitor at
5- and 25-fold excess respectively. Lanes 5 and 6, unlabelled
BAG1 mutant competitor at 5-, 25-fold excess. Lane 7, ﬁvefold
excess unlabelled B-NTPase competitor.
1512 M. S. Behnke etal. 
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Molecular Microbiology, 68, 1502–1518peted for all protein(s) forming complexes 1–3, whereas
mutant DNA competed only for complexes 1 and 2. Pro-
teins forming complex 3 with labelled WT-DNA remained
unaffected or were enhanced by the addition of mutant
BAG1 DNA, suggesting this is the functionally relevant
binding activity. As with the lack of competition of unla-
belled BAG1 DNA in the B-NTPase DNA EMSA assays
(Fig. 7), we observed little cross-competition with 5¥
excess B-NTPase DNA when using labelled BAG1 DNA
fragments.
Discussion
There is strong experimental evidence that apicomplexan
parasitespossessbipartitepromoterswithbasalandregu-
lated cis-elements similar to other eukaryotes (Horrocks
et al., 1998). As a consequence, genomic regions
upstream of several Toxoplasma genes have served as
promoters in vector constructs (White et al., 2007). While
relatively few of these promoters have been characterized
in detail, they appear to work autonomously (without the
need for the respective gene speciﬁc-3′ regions) via inter-
nal sequence elements in a constitutive or stage-speciﬁc
manner(SoldatiandBoothroyd,1995;Mercieret al.,1996;
Bohne et al., 1997; Roos et al., 1997; Nakaar et al., 1998;
Matrajt et al., 2004; Ma et al., 2004; Kibe et al., 2005).
Studies of a few bradyzoite genes are consistent with the
principle that mRNA induction is regulated by gene pro-
ximal elements in Toxoplasma; however, these earlier
investigations did not clearly deﬁne promoter cis-acting
sequences that are required and sufficient for the regula-
tionofbradyzoitegeneexpression(SoldatiandBoothroyd,
1995; Mercier et al., 1996; Bohne et al., 1997; Roos et al.,
1997; Nakaar et al., 1998; Ma et al., 2004; Matrajt et al.,
2004; Kibe et al., 2005). Utilizing the dual luciferase assay
in in vitro induction models, we show that regions no more
than 1500 bp upstream of various bradyzoite genes are
able to induce luciferase expression in multiple strains and
under different bradyzoite induction conditions. Cis-acting
elements in several bradyzoite promoters were mapped
leading to the identiﬁcation of short sequences that were
involved in controlling gene expression. Two of these pro-
moters, BAG1 and B-NTPase were ﬁne mapped to a
6–8 bp resolution (Fig. 4 and Table 1) and these mapped
elements were capable of converting a constitutive pro-
moter to one that is induced by bradyzoite conditions. It is
interesting to note that these elements do not contain any
single nucleotide polymorphism across the three major
lineages (data not shown). Protein binding assays demon-
strate that these sequences exhibit unique and speciﬁc
banding patterns, suggesting they are bound by factors,
which recognize the particular cis-elements (Figs 7 and 8).
Altogether these results conﬁrm that transcription initiation
is a major mechanism controlling parasite development
and these studies are the ﬁrst to identify the minimal
sequence elements that are sufficient for bradyzoite gene
expressionandtoshowproteinbindingspeciﬁcityforthose
elements.
The presence of the general eukaryotic transcriptional
machinery and a full complement of chromatin remodeling
enzymes in apicomplexan parasites are consistent with
transcription serving a major role in these parasites. This
model is well supported by recent studies that demon-
strate primary developmental transitions leading to forma-
tion of the Toxoplasma tissue cyst are accompanied by
a temporally ordered set of transcriptional events from
genesthataredispersedacrossallparasitechromosomes
(Cleary et al., 2002; Singh et al., 2002; Radke et al., 2005)
(see also Fig. 1). Similar observations have been made in
Plasmodium, which has lead to the ‘just in time’hypothesis
for those selected genes regulated during development
(Bozdech et al., 2003; Llinas and DeRisi, 2004). Despite
theimportanceoftranscriptiontoapicomplexanlifecycles,
the mechanistic details of regulated gene expression are
poorly understood in these parasites. The abundance of
chromatin remodeling machinery conserved in the Api-
complexa has led to the speculation that gene expression
might be controlled primarily by epigenetic processes
(Saksouk et al., 2005; Sullivan and Hakimi, 2006; Hakimi
and Deitsch, 2007), but this model lacks elements of
speciﬁcity that would be needed to explain the strict tem-
poral patterns of gene expression that unfold during para-
site development. Data presented here suggest that gene
proximal cis-elements are required to initiate developmen-
tal gene expression, most likely by the binding of gene-
speciﬁc trans-acting factors. Moreover, ChIP assays on
the three major lineages indicate that histone acetylation
patterns does not always correlate with mRNAexpression
as there is substantial H3 acetylation associated with a
number of bradyzoite promoters in parasites maintained
as tachyzoites where mRNA expression is nearly too low
to be detected (Kissinger et al., 2003; Radke et al., 2005)
(Figs 1, 2Aand B).Acetylation of these bradyzoite promot-
ers is not substantially increased or changed in most of the
parasite strains stimulated to differentiate whose conver-
sion to the tissue cyst form is either low (Type I) or high
(Type II and III). These results are in contrast to recent
reports that suggested a higher correlation between H3
acetylation patterns and changes in developmental mRNA
expression in Toxoplasma (Saksouk et al., 2005; Gissot
et al., 2007). It is possible that the difference between
these studies lies in the early passage strains used here
and that long-term adaptation of the tachyzoite stage to
cell culture may lead to epigenetic changes in bradyzoite
promoters; the hypoacetylated patterns that were preva-
lent in the classic culture strain Type I-RH shown here are
consistent with this idea. These results do not rule out
a role for chromatin remodeling in the regulation of
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histone acetylation alone are not sufficient to account for
the transcriptional changes we have measured in primary
strains of Toxoplasma.
The failure of database mining to ﬁnd large numbers of
transcription factors in apicomplexan genome sequence
(Templeton et al., 2004; Meissner and Soldati, 2005) has
also contributed to the search for alternate explanations of
gene regulation in these parasites (Meissner and Soldati,
2005). Given that comparative genomics depends on a
level of similarity that might not apply to these parasites,
the explanation could lie in the uniqueness of transcription
factors in the Apicomplexa (Meissner and Soldati, 2005).
This explanation is supported by the recent computation-
ally derived identiﬁcation of a family of apicomplexan DNA
binding proteins containing the AP2-integrase binding
domain (Balaji et al., 2005; Iyer et al., 2008). Alternatively,
fewer transcription factors might indicate that only a few
factors are required to control the mRNA pool structure
unique to each development stage (Radke et al., 2005)
and that most genes are controlled by a limited but
common set of basal transcription factors. One prediction
fromthismodelisthattranscriptioningeneralmightbeless
ﬂexible and this is supported by a nearly complete lack of
transcriptional response observed in intracellular Toxo-
plasma tachyzoites that are metabolically altered by drug
or gene knockout leading to parasite death (B. Striepen,
G.G. van Dooren and M.W. White, unpubl. results). A
second prediction of fewer transcriptionally responsive
genes is that the pool of mRNAs evaluated by frequency
would have a lower complexity. Based on an extensive
analysis of the Toxoplasma transcriptome by SAGE, we
have found a substantially different mRNA pool present in
this parasite when compared with higher eukaryotes or to
anon-parasiticunicellulareukaryotesuchasSaccharomy-
ces (Radke et al., 2005). Relatively few genes (< 5%)
account for nearly 75% of all transcripts in the intermediate
life cycle stages of this parasite (Radke et al., 2005) and
the abundant mRNAclass in this parasite is populated with
transcripts that encode apicomplexa-speciﬁc genes. Many
of the abundant genes are developmentally regulated and
ﬁve of these genes were the subject of this study and were
shown to be regulated by conventional promoter mecha-
nisms that involve speciﬁc cis-acting elements.
In conclusion, the lack of knowledge about gene-
speciﬁc transcription factors is one of the major gaps in
Toxoplasma biology, and ﬁlling this deﬁciency has impor-
tant implications for developing treatments that prevent
tissue cyst formation. The data presented here increase
our understanding of promoter control in the developmen-
tal progression of Toxoplasma from the tachyzoite to the
bradyzoite and sets the foundation needed to utilize bio-
chemical approaches in identifying bradyzoite transcrip-
tion factors.
Experimental procedures
Cell culture and parasite strains
Low passage strains used in these studies were Type I-GT1,
the genome reference strain Type II-Me49B7 and Type III-
CTG. The following laboratory strains were also used: Type
I-RH strain is a well-established lab strain that has lost the
ability to complete the two-host life cycle, Type II-Prugniaud
strain is capable of robust bradyzoite differentiation and was
used to generate stable transgenic lines, and ﬁnally, the Type
III-VEGmsj has a low frequency of spontaneous differentiation
when cultured under tachyzoite conditions but is strongly
induced to differentiate under a variety of conditions. Type
III-VEGmsj was used for all deletion/mutagenesis promoter
mapping studies. All strains were maintained by serial
passage in human foreskin ﬁbroblasts (HFF) cultured in Dul-
becco’s modiﬁed Eagle medium (DMEM, Gibco BRL, Grand
Island, NY) supplemented with 1% (v/v) fetal bovine serum
(FBS; Atlanta Biologicals, Lawrenceville, CA). Compound 1
was used at a working concentration of 3 mMi n1 %F B S
DMEM media; pH 8.2 media were made with tricine buffered
(45 mM) DMEM without sodium bicarbonate (Cellgro,
Herndon, VA) adjusted to pH 8.2 with KOH; L-arginine
depleted media were obtained from Specialty Media (Phillips-
burg, NJ); parasites shifted to the CO2-depleted condition
were grown in media made with tricine buffered (45 mM)
DMEM without sodium bicarbonate (Cellgro) adjusted to pH 7
with KOH in a CO2-free environment; and parasites shifted to
high temperature conditions were grown in regular 1% FBS
DMEM media at 40°C.
Microarray analysis
Parasiteswerepuriﬁedfromhostcellsaspreviouslydescribed
(Roos et al., 1994) and RNA was extracted using the Qiagen
RNeasy kit: with b-mercaptoethanol and DNase I treatment
(Valencia, CA). RNAquality was determined using theAgilent
Bioanalyzer 2100 (Santa Clara, CA). A total of 3 mg starting
RNA was used to produce cRNA using the Affymetrix One-
Cycle Kit (Affymetrix, Santa Clara, CA). Fragmented cRNA
(5 mg) was hybridized to the Toxoplasma gondii Affymetrix
microarray according to standard hybridization protocols
(please refer to http://roos-compbio2.bio.upenn.edu/~abahl/
Array-Tutorial.html for a detailed description of array design
and features). Two hybridizations were done for each sample
type.HybridizationdatawerepreprocessedwithRobustMulti-
array Average (RMA) and normalized using per chip and per
gene median polishing and analysed using the software
package GeneSpring 7.2 (Agilent Technologies, Santa Clara,
CA). The following procedure was used to identify the 267
genes induced by Compound 1: Student’s t-test grouped
by the Compound 1 parameter, variances assumed equal,
P-valuecut-off0.05,BenjaminiandHochbergFalseDiscovery
Rate, using all samples except Type I-GT1 CMPD1 as its lack
of induction confounded the use of the Compound 1 param-
eter) Pearson correlations between independent replicates:
strain Type III-CTG tachyzoite = 0.976, strain Type III-CTG-
CMPD1 induced = 0.976, strain Type I-GT1 tachyzoite =
0.945,strainTypeI-GT1-CMPD1induced = 0.982,strainType
II-Me49B7 tachyzoite = 0.968, and strain Type II-Me49B7-
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of 8131 total probes: Type III-CTG tachyzoite = 68%, Type
III-CTG-CMPD1 = 70%, Type I-GT1 tachyzoite = 62%, Type
I-GT1-CMPD1 = 75%,TypeII-Me49B7tachyzoite = 70%,and
Type II-Me49B7-CMPD1 = 71%.
Chromatin immunoprecipitation
Freshly lysed tachyzoites or in vitro bradyzoites were treated
for 10 min with 1% formaldehyde at 37°C, spun and
re-suspended in cold lysis buffer (1% SDS, 10 mM EDTA,
50 mM Tris-HCL, pH 8.1, plus protease inhibitors). Samples
forChIPconsistedof~5 ¥ 10
7parasitesthatweresubjectedto
sonication on ice three times, 10 s each. The following steps
were carried out at 4°C unless indicated otherwise. Samples
were centrifuged at 13 000 r.p.m. for 10 min, and a portion of
thesupernatantwassavedforinputDNA.Therestwasdiluted
10-fold in ChIPdilution buffer (0.01% SDS, 1.1%Triton X-100,
1.2 mM EDTA, 16.7 mM Tris-HCl, 167 mM NaCl, pH 8.1) plus
protease inhibitor cocktail (Sigma P8340). Lysate was pre-
cleared with 80 ml salmon sperm DNA protein A agarose for
30 min with agitation. Following centrifugation at 1000 r.p.m.
for 1 min, anti-AcH3 or anti-AcH4 (Upstate Biotechnology
06–599 and 06–866 respectively) was added for an overnight
incubation. Then 60 ml of salmon sperm DNA/protein-A
agarose was added and incubated for 1 h to collect the
antibody–protein–DNA complex. The resulting complex was
washed 2¥ with 1.0 ml of each of the following buffers for
5 min:lowsaltwashbuffer(0.1%SDS,1%TritonX-100,2 mM
EDTA,20 mMTris-HCl,150 mMNaCl,pH 8.1);highsaltwash
buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM
Tris-HCl, 500 mM NaCl, pH 8.1); LiCl wash buffer (0.25 M
LiCl, 1% NP40, 1% deoxycholate, 1 mM EDTA, 10 mM Tris-
HCl,pH 8.1).Sampleswerewashed4¥inTEpriortoelutionin
250 ml elution buffer (1% SDS, 0.1 M NaHCO3) for 15 min at
room temperature with agitation.After a spin at 1000 r.p.m. for
1 min, a second elution step was performed on the superna-
tant. NaCl (20 ml of 5 M) was added to the combined eluates
and cross-links were reversed by heating for 4 h at 65°C.
Samples were then treated with proteinase K and DNArecov-
ered by phenol/chloroform extraction followed by ethanol pre-
cipitation. Standard PCRs were carried out with designated
primers (see Table S2) using Taq polymerase (Invitrogen),
and products visualized on a 1% agarose gel containing
0.5 mgm l
-1 ethidium bromide. Regions ampliﬁed from putative
start ATG: BAG1 =- 979 to -263, LDH2 =- 810 to -43,
SAG2A =- 438 to -1, B-NTPase =- 1280 to -753.
Promoter deletion, substitution and
mutagenesis constructs
In order to construct a renilla version of the DCAT-pluc-ﬁreﬂy
luciferase (Matrajt et al., 2002), the renilla coding region was
ampliﬁed by PCR with primers that incorporated Avr-II/Pst-1
restriction sites. This DNAfragment was then used to replace
the ﬁreﬂy coding region in the DCAT-pluc-ﬁreﬂy luciferase
plasmid. To prepare destination vectors for cloning various
promoter-5′-UTR genomic fragments, we replaced the
existing promoter and DCAT regions (Kpn1/AvrII) in the
DCAT-pluc-ﬁreﬂy luciferase and DCAT-pluc-renilla-luciferase
plasmids with an oligonucleotide linker that contained KpnI/
SmaI/AvrII sites. The unique SmaI site was then used to
clone the cassette B fragment that carries the ccdB and
chloramphenical resistance markers for eventual recombina-
tional cloning (Invitrogen, Carlsbad, CA). The placement of
the cassette B in these plasmids enabled recombinational
cloning of promoter fragments 5′ of the ﬁreﬂy or renilla coding
regions. Promoter fragments included 5′-ﬂanking genomic
sequence including the 5′-UTR and the translational start.
The attB2 sequence is translated and in frame with the
luciferase coding region. The resulting plasmids were
renamed DEST-p-ﬁreﬂy parent or DEST-p-renilla-parent and
carried the ampicillin resistance marker for selection in
bacteria, although no Toxoplasma selection marker was
included.
Sequential deletion constructs were made by amplifying
the appropriate promoter and 5′-UTR regions from Type II
genomic DNA for each gene tested using primers containing
ﬂanking the attB1 and attB2 sites. The promoter fragment
was ﬁrst cloned into pDONR221 (Invitrogen) via the BP reac-
tion, and after restriction enzyme veriﬁcation, the promoter
fragment was moved into either of the destination vectors
above via the LR reaction (Invitrogen). Nucleotide positions in
these deletion studies are referenced with respect to the start
of translation (+1).
Substitution and site-directed mutagenesis constructs
were obtained by alterations of the appropriate pDONR221
entry vector containing the promoter fragment of interest by
using this plasmid as a template for inverse PCR where the
plasmid was ﬁrst ampliﬁed and then re-ligated following
digestion of ArvII sites incorporated into the primer designs.
Constructs were veriﬁed with restriction enzyme mapping,
and then modiﬁed promoter moved to the Dest-p-ﬁreﬂy vector
via the LR reaction.
Dual luciferase assay
Parasites were electroporated as previously described
(Striepen et al., 2002) with a combination of the Dest-p-ﬁreﬂy
promoter construct of choice (40 mg) and the control Dest-p-
renilla-a-tubulin plasmid (20 mg). Electroporations were per-
formed in duplicate with each electroporated sample split
equally into two T25cm
2 ﬂasks (control and experimental) and
allowed to grow ~16 h at 37°C. Following the period of over-
night recovery, bradyzoite inductive media or culture condition
was applied to two experimental ﬂasks. Samples were pro-
cessed for luciferase activity by scraping the infected mono-
layer,harvestingthecellsbycentrifugationandre-suspending
the cell pellet in 1¥ Lysis Buffer (Promega, Madison, WI). The
lysates were vortexed, incubated at room temperature for
15 min, then centrifuged for 5 min at 14 000 r.p.m. (tabletop
microcentrifuge) and kept on ice until assayed for luciferase
activity. Fireﬂy and renilla luciferase activity was determined
in the same extract using Promega Dual Luciferase Assay
reagents according to manufacturer protocols (Promega) and
light readings taken on a Lumat LB 9507 luminometer. Four
readings were collected for ﬁreﬂy and renilla luciferase activity
for each promoter construct. Fireﬂy luciferase results were
normalized by a-tubulin-renilla levels and referenced to the
induced expression levels of a control promoter construct
(relative response ratio) or compared with the control
Transcriptional control in T.gondii 1515
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Molecular Microbiology, 68, 1502–1518a-tubulin-renilla promoter construct (fold change). All con-
structs (control, deletion or mutant) were expressed > 10-fold
(typically > 100-fold) over non-speciﬁc background (30 light
units on average) following induction.
Preparation of BAG1-LUC transgenic parasites
Type II-Prugniaud, was co-electroporated with a plasmid
(45 mg) carrying the ﬁreﬂy luciferase region under control of
thefull-lengthBAG1promoter(1195 bp5′-ﬂankingregion)and
the plasmid pC3 (5 mg), which encodes the pyrimethamine
resistance marker (Donald and Roos, 1993). Following an
overnight recovery in normal culture media, the parasites
were selected in media containing 1 mM pyrimethamine.
Pyrimethamine-resistant parasites were then cloned by
limited dilution and clones tested for luciferase activity under
Compound 1 or alkaline media induction. Clone IC2 was one
of several clones that displayed strong luciferase induction
under bradyzoite induction conditions (data not shown).
Protein extracts and EMSA assays
Type III-CTG parasites induced by 3 mM Compound 1 for 48 h
were harvested and protein extracts produced using NE-PER
nuclear and cytoplasmic extraction reagents according to
manufacturer protocols (Pierce, Rockford, IL). Oligonucle-
otide probes were hybridized and then end-labelled by incor-
poration of [
32P] using 5 units of T4 polynucleotide kinase
(USB, Cleveland, OH) and 10 mCi ml
-1 [g-
32P]-ATP substrate
(Amersham Biosciences, Piscataway, NJ). Unincorporated
nucleotides were removed with NucAway spin columns
(Ambion, Austin, TX) and the probes stored at -20°C.
EMSA binding reactions contained 200 ng polydI:dC,
12.5 mg BSA, 10 mM DTT, 7.5 mM MgCl2, 67% Buffer D
(20 mM HEPES, 20% v/v glycerol, 0.2 mM EDTA, 100 mM
KCL, the following were added fresh 0.5 mM PMSF, and
1 mM DTT). Approximately 1 fmol of puriﬁed radiolabelled
oligonucleotide and 10 mg of protein extract in reaction buffer
were incubated on ice for 1 h, loaded directly onto a 4.5%
native acrylamide gels (pre-electrophoresed at 20 mA for
1.5 h at 4°C), and the complexes were resolved at 40 mA for
2.5 h at 4°C in running buffer (0.5¥ TBE, 1% glycerol). The
gels were transferred to whatman, dried and exposed to a
phosphorimaging screen. All EMSA assays were performed
at < 50% probe shift in order to compare the levels of
complex formation between reactions.
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